Bladder Cancer Clinical Trial
Permission to Collect Blood Over Time for Research
Summary
To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of individuals who will go on to develop a clotting complication.
Eligibility Criteria
Inclusion Criteria:
Male or female, >= 18 years old. There are no ethnic restrictions.
Active cancers of the GI tract (gastroesophageal, colorectal, or pancreatic-biliary) that have completed TNM staging by the American Joint Committee on Cancer; stage III disease if diagnosed within 2 months and all stage IV disease
Ability to understand and the willingness to sign a written informed consent document.
Existing staging CT imaging study
Exclusion Criteria:
Life expectancy < 6 months
History of deep vein thrombosis (DVT) or pulmonary embolism (PE)
Known pregnancy or positive urine pregnancy test in pre-menopausal women
On anticoagulant therapy (heparin, warfarin, direct thrombin inhibitors)
No CT imaging studies, or contraindications to undergoing CT imaging
Existing or anticipated need for a tunneled central venous catheter
Clinic visitation to Stanford Cancer center for secondary consultation purposes only
Inability to give informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Stanford California, 94305, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.